Scientific Sessions 2025  /  New Insights and Treatment Options in Diabetes Associated Cardiometabolic Disease  /  Development of mimetic peptides that slow progression and promote regression of type 1 diabetes mellitus
Logo

American Heart Association

  63
  0

Final ID:

Development of mimetic peptides that slow progression and promote regression of type 1 diabetes mellitus

  • Rye, Kerry-anne  ( UNIV NEW SOUTH WALES , Sydney , New South Wales , Australia )
  • Cochran, Blake  ( UNSW Sydney , Unsw Sydney , New South Wales , Australia )
    • Author Disclosures:
    Kerry-Anne Rye: DO NOT have relevant financial relationships | Blake Cochran: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

New Insights and Treatment Options in Diabetes Associated Cardiometabolic Disease

Friday, 11/07/2025 , 02:15PM - 03:30PM

Cardiovascular Seminar

More abstracts on this topic:
Type 1 diabetes mellitus and atherosclerosis

Bornfeldt Karin, Kanter Jenny

Targeting Endothelial IGF2 Ameliorates Wound Healing in Diabetes

Chen Hong, Shi Jinjun

More abstracts from these authors:
Partial loss of macrophage Ripk1 drives atheroprotection in Ldlr-/- Mice and is controlled by ApoAI–IL-10-STAT3 anti-inflammatory signaling.

Xu Han, Nicholls Stephen, Murphy James, Bursill Christina, Rye Kerry-anne, Karunakaran Denuja, Sato Masaaki, Fernando Shevin, Cochran Blake, Nankivell Victoria, Tapia Caceres Felipe, Wang Yizhuo, Bisht Kavita, Denton Kate

The JLR

Rye Kerry-anne

You have to be authorized to contact abstract author. Please, Login
Not Available